BOSTON, March 24 (Reuters) - Billionaire investor William Ackman, whose hedge fund is one the of the biggest investors in drug company Valeant, has been asked to supply information to U.S. legislators probing price hikes in the pharmaceutical industry.
Read more
No comments:
Post a Comment